NCT01398410 - Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) | Biotech Hunter

Enrollment

405

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

February 28, 2014

Conditions

Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin

Interventions

DRUG

Rabeprazole

Participants received rabeprazole 5 mg tablets and rabeprazole 10 mg matched placebo tablets orally, once daily

DRUG

Rabeprazole

Participants received rabeprazole 10 mg tablets and rabeprazole 5 mg matched placebo tablets orally, once daily

Trial Locations (50)

Unknown

Kasugai

Nagoya

Ichikawa

Chikushino-shi

Fukuoka

Kitakyushu

Koga

Gifu

Maebashi

Asahikawa

Sapporo

Tomakomai

Itami

Kobe

Hitachi

Fujisawa

Kawasaki

Sagamihara

Yokohama

Kitakyushu

Kochi

Hitoyoshi

Kumamoto

Kyoto

Ebino

Miyazaki

Chikuma

Matsumoto

Nagano

Suzaka

Nagasaki

Beppu

Ōita

Yufu

Daitō

Hirakat

Matsubara

Osaka

Takatsuki

Yao

Karatsu

Saga

Ureshino

Izumo

Hamamatsu

Shizuoka

Ohtawara

Mitaka

Setagaya City

Shinjuku

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY